Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomechanical effects of duloxetine in stress incontinence
NCT00190567Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in stress urinary incontinence (SUI) comparing Duloxetine with Placebo (2 arms). Primary endpoint: Vesical Valsalva Leak Point Pressure. Started Oct 2001; status: completed.
02
Drugs
duloxetine
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT00190567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190567.